Results 121 to 130 of about 332,084 (209)

Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy - protocol of a multicentre, single arm phase 2 trial (SAKK 06/19). [PDF]

BMJ Open, 2023
Petrausch U, Spahn M, Schneider M, Hayoz S, Rentsch CA, Rothschild S, Omlin A, Cathomas R.   +7 more
europepmc   +1 more source

Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice. [PDF]

Vaccines (Basel), 2022
Fol M, Włodarczyk M, Kowalewicz-Kulbat M, Druszczyńska M, Krawczyk KT, Wawrocki S, Rudnicka W, Chmiela M.   +7 more
europepmc   +1 more source

[BCG vs. BCG plus recombinant alpha-interferon 2b in superficial tumors of the bladder].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 1995
BCG intravesical instillation is a well established therapy for superficial bladder carcinoma as adjuvant and/or prophylactic treatment. However side-effects are frequent when full doses are employed and therefore low dose alternative schedules were proposed.
E, Bercovich, M, Deriu, F, Manferrari, G, Irianni   +3 more
openaire   +1 more source

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus. [PDF]

Front Immunol, 2021
Díaz FE, Guerra-Maupome M, McDonald PO, Rivera-Pérez D, Kalergis AM, McGill JL.   +5 more
europepmc   +1 more source

Long-term stability of the GMP-compliant recombinant BCG vaccine against human RSV under quality control analyses. [PDF]

iScience
Troncoso-Bravo T, Rivera DB, Ramírez MA, Loaiza RA, Reyes A, Pavez V, Kourounis D, Tsatsara KP, Horefti E, Martinez-Gonzalez B, Rabias I, Peñaloza HF, González PA, Bueno SM, Kalergis AM.   +14 more
europepmc   +1 more source

Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice. [PDF]

Arch Microbiol
Lanius SL, Pacheco BS, Sousa FSS, Neto ACPS, Scholl NR, Cardozo SJF, Ehlert ME, Ferreira VG, Collares TV, Borsuk S, Dellagostin O, Bohn TLO, Seixas FK.   +12 more
europepmc   +1 more source

Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge. [PDF]

J Immunol, 2023
Mambelli F, Marinho FV, Andrade JM, de Araujo ACVSC, Abuna RPF, Fabri VMR, Santos BPO, da Silva JS, de Magalhães MTQ, Homan EJ, Leite LCC, Dias GBM, Heck N, Mendes DAGB, Mansur DS, Báfica A, Oliveira SC.   +16 more
europepmc   +1 more source

T cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2. [PDF]

Hum Vaccin Immunother
Mambelli F, Gimenez AM, de Araujo ACVSC, Ramos KKS, Farias JP, de Freitas CL, Paludo GP, Cortes N, Dos S Alves RP, Minoprio P, Leite LCC, Ferreira LCS, Oliveira SC.   +12 more
europepmc   +1 more source

New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19? [PDF]

Cell Immunol, 2020
Gupta PK.
europepmc   +1 more source

Improved immune responses and tuberculosis protection by aerosol vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum. [PDF]

PLoS Pathog
Sayes F, Frigui W, Pawlik A, Tillier C, Tichit M, Hardy D, Brosch R.   +6 more
europepmc   +1 more source